049960 — Cell Biotech Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩83bn
- KR₩14bn
- KR₩54bn
- 95
- 76
- 70
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 7,231 | 3,189 | 10,383 | 8,281 | 6,304 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 751 | 2,136 | -884 | 1,030 | -1,282 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -372 | 555 | 1,604 | -134 | -1,111 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 10,231 | 9,564 | 14,892 | 12,814 | 7,815 |
Capital Expenditures | -9,709 | -3,093 | -967 | -2,673 | -1,686 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 5,319 | 1,466 | -10,164 | -3,996 | -3,059 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -4,390 | -1,627 | -11,132 | -6,669 | -4,745 |
Financing Cash Flow Items | 0 | — | — | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -9,617 | -7,616 | -3,858 | -7,538 | -3,721 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3,920 | 177 | 260 | -1,402 | -573 |